Letters GLP-1R agonists and weight loss

Utility of GLP-1R agonists in diabetes requires long term study

BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e1451 (Published 28 February 2012) Cite this as: BMJ 2012;344:e1451
  1. Jose Mario Franco de Oliveira, associate professor of medicine1
  1. 1Department of Medicine, Universidade Federal Fluminense, Rio de Janeiro, RJ 22230-001, Brazil
  1. jmariofranco{at}gmail.com

What is the clinical relevance to diabetes treatment of the meta-analysis of the effects of glucagon-like peptide-1 receptor (GLP-1R) agonists on weight loss, …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe